These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma. Andersen MN; Andersen NF; Rødgaard-Hansen S; Hokland M; Abildgaard N; Møller HJ Leuk Res; 2015 Sep; 39(9):971-5. PubMed ID: 26169445 [TBL] [Abstract][Full Text] [Related]
5. Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation. De Beule N; De Veirman K; Maes K; De Bruyne E; Menu E; Breckpot K; De Raeve H; Van Rampelbergh R; Van Ginderachter JA; Schots R; Van Valckenborgh E; Vanderkerken K J Pathol; 2017 Mar; 241(4):534-546. PubMed ID: 27976373 [TBL] [Abstract][Full Text] [Related]
7. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus. Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016 [TBL] [Abstract][Full Text] [Related]
8. Antibody combinations for optimized staining of macrophages in human lung tumours. Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134 [TBL] [Abstract][Full Text] [Related]
9. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration. Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes. Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841 [TBL] [Abstract][Full Text] [Related]
11. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696 [TBL] [Abstract][Full Text] [Related]
13. CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow. Fischer-Riepe L; Daber N; Schulte-Schrepping J; Véras De Carvalho BC; Russo A; Pohlen M; Fischer J; Chasan AI; Wolf M; Ulas T; Glander S; Schulz C; Skryabin B; Wollbrink Dipl-Ing A; Steingraeber N; Stremmel C; Koehle M; Gärtner F; Vettorazzi S; Holzinger D; Gross J; Rosenbauer F; Stoll M; Niemann S; Tuckermann J; Schultze JL; Roth J; Barczyk-Kahlert K J Allergy Clin Immunol; 2020 Nov; 146(5):1137-1151. PubMed ID: 32199911 [TBL] [Abstract][Full Text] [Related]
14. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
15. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932 [TBL] [Abstract][Full Text] [Related]
16. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307 [TBL] [Abstract][Full Text] [Related]
17. Mass Cytometry Discovers Two Discrete Subsets of CD39 Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S Front Immunol; 2019; 10():1596. PubMed ID: 31428081 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Shabo I; Stål O; Olsson H; Doré S; Svanvik J Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688 [TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment. Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181 [TBL] [Abstract][Full Text] [Related]